Use of Zephyr stent in congenital heart diseases: A single-center study
Large vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific “S-” and “C-” shaped flexible polylinks prevent stent foreshortening and recoil. We report ou...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Annals of Pediatric Cardiology |
| Subjects: | |
| Online Access: | http://www.annalspc.com/article.asp?issn=0974-2069;year=2023;volume=16;issue=4;spage=276;epage=281;aulast=Bandyopadhyay |
| _version_ | 1797300104062828544 |
|---|---|
| author | Sudipta Bandyopadhyay Muthukumaran Chinnaswamy Sivaprakasam |
| author_facet | Sudipta Bandyopadhyay Muthukumaran Chinnaswamy Sivaprakasam |
| author_sort | Sudipta Bandyopadhyay |
| collection | DOAJ |
| description | Large vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific “S-” and “C-” shaped flexible polylinks prevent stent foreshortening and recoil. We report our experience of using Zephyr among the pediatric population and their medium-term outcome. The study included a total of 19 patients treated with 21 Zephyr stents. The indications for stenting included coarctation of the aorta (four patients), stenosed pulmonary artery (eight patients), stenosed right ventricular outflow tract (five patients) or conduit (one patient), and percutaneous Fontan (one patient). All the procedures were successful. None of the patients showed any stent-related complications. Stent fractures, foreshortening, or recoil were not seen during follow-up. Our medium-term (1–20 months) follow-up showed a favorable outcome. One patient developed restenosis. Zephyr stent is a good therapeutic option for large-vessel stenting. However, it needs large-scale studies for further confirmation. |
| first_indexed | 2024-03-07T23:01:24Z |
| format | Article |
| id | doaj.art-aedc431ee0f0448dadb49c1d2b475fc9 |
| institution | Directory Open Access Journal |
| issn | 0974-2069 |
| language | English |
| last_indexed | 2024-03-07T23:01:24Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Annals of Pediatric Cardiology |
| spelling | doaj.art-aedc431ee0f0448dadb49c1d2b475fc92024-02-22T14:40:10ZengWolters Kluwer Medknow PublicationsAnnals of Pediatric Cardiology0974-20692023-01-0116427628110.4103/apc.apc_78_23Use of Zephyr stent in congenital heart diseases: A single-center studySudipta BandyopadhyayMuthukumaran Chinnaswamy SivaprakasamLarge vessel stenosis is currently successfully treated with percutaneous stent implantation. Zephyr stent is a cobalt-chromium peripheral stent specifically designed for large-vessel stenting. Its specific “S-” and “C-” shaped flexible polylinks prevent stent foreshortening and recoil. We report our experience of using Zephyr among the pediatric population and their medium-term outcome. The study included a total of 19 patients treated with 21 Zephyr stents. The indications for stenting included coarctation of the aorta (four patients), stenosed pulmonary artery (eight patients), stenosed right ventricular outflow tract (five patients) or conduit (one patient), and percutaneous Fontan (one patient). All the procedures were successful. None of the patients showed any stent-related complications. Stent fractures, foreshortening, or recoil were not seen during follow-up. Our medium-term (1–20 months) follow-up showed a favorable outcome. One patient developed restenosis. Zephyr stent is a good therapeutic option for large-vessel stenting. However, it needs large-scale studies for further confirmation.http://www.annalspc.com/article.asp?issn=0974-2069;year=2023;volume=16;issue=4;spage=276;epage=281;aulast=Bandyopadhyaybranch pulmonary artery stentingcoarctation of the aortapercutaneous fontanright ventricular outflow tractzephyr stent |
| spellingShingle | Sudipta Bandyopadhyay Muthukumaran Chinnaswamy Sivaprakasam Use of Zephyr stent in congenital heart diseases: A single-center study Annals of Pediatric Cardiology branch pulmonary artery stenting coarctation of the aorta percutaneous fontan right ventricular outflow tract zephyr stent |
| title | Use of Zephyr stent in congenital heart diseases: A single-center study |
| title_full | Use of Zephyr stent in congenital heart diseases: A single-center study |
| title_fullStr | Use of Zephyr stent in congenital heart diseases: A single-center study |
| title_full_unstemmed | Use of Zephyr stent in congenital heart diseases: A single-center study |
| title_short | Use of Zephyr stent in congenital heart diseases: A single-center study |
| title_sort | use of zephyr stent in congenital heart diseases a single center study |
| topic | branch pulmonary artery stenting coarctation of the aorta percutaneous fontan right ventricular outflow tract zephyr stent |
| url | http://www.annalspc.com/article.asp?issn=0974-2069;year=2023;volume=16;issue=4;spage=276;epage=281;aulast=Bandyopadhyay |
| work_keys_str_mv | AT sudiptabandyopadhyay useofzephyrstentincongenitalheartdiseasesasinglecenterstudy AT muthukumaranchinnaswamysivaprakasam useofzephyrstentincongenitalheartdiseasesasinglecenterstudy |